Search details
1.
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design.
Lancet
; 399(10336): 1695-1707, 2022 04 30.
Article
in English
| MEDLINE | ID: mdl-35405085
2.
Psychometric validation of the Spanish version of the Expanded Prostate Cancer Index Composite-26.
World J Urol
; 41(12): 3511-3518, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37947846
3.
Hyperprogression after first dose of immunotherapy in a patient with radioresistant metastasis from nonsmall cell lung cancer.
Anticancer Drugs
; 30(10): 1067-1070, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31567311
4.
Management of high-risk and post-operative non-metastatic prostate cancer in Catalonia: an expert Delphi consensus.
Clin Transl Oncol
; 25(4): 1017-1023, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36436177
5.
Results of the IROCA international clinical audit in prostate cancer radiotherapy at six comprehensive cancer centres.
Sci Rep
; 11(1): 12323, 2021 06 10.
Article
in English
| MEDLINE | ID: mdl-34112863
6.
Corticotomy in orthodontic treatment: systematic review.
Heliyon
; 6(5): e04013, 2020 May.
Article
in English
| MEDLINE | ID: mdl-32490239
Results
1 -
6
de 6
1
Next >
>>